TAGLN and neoplasm: HOPX (4.26/4.11-fold) is a known colon stem cell marker and is associated with the suppression of tumor metastasis [24], and TAGLN (2.66/3.73-fold) was found as a novel tumor suppressor and its post-surgical high expression was reported to be associated with good prognosis in stage III CRCs [25].